Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema flares, but atopic dermatitis increases the risk for mental health issues due ...

Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...

Patients with suspected eyelid allergic contact dermatitis can benefit from patch testing beyond common allergens.

If you’ve been experiencing symptoms of atopic dermatitis, you may have an appointment with a dermatologist coming up, or thinking about scheduling one. Get ready for your visit by learning from the ...

Perioral dermatitis is a skin condition characterized by a rash around the mouth. It is one type of dermatitis, which is a general term for skin irritation. In the word “perioral,” “peri ...

There are two types of dermatitis that can affect the vulva or any other area of the body. Both involve an abnormal response of the immune system. Contact dermatitis is skin inflammation caused by ...

In an allergic contact dermatitis reaction, the allergen stimulates T cells to react to produce the effects rather than stimulating the production of IgE. Irritant contact dermatitis can also occur, ...

Limit the amount of time your skin comes into contact with the elements. The sun’s ultraviolet rays, heat, and wind can aggravate perioral dermatitis. Some medications used to treat perioral ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in ...

Venous stasis dermatitis, or varicose eczema, involves swollen and itchy discolored skin on the lower legs. It usually occurs when venous insufficiency leads to varicose veins. It can lead to ...

ORLANDO, Fla. — In a phase 3 atopic dermatitis (AD) trial, rocatinlimab, a novel therapy that targets T cells expressing the OX40 receptor, showed efficacy on both coprimary and key secondary ...